Collective Family Office’s Gilead Sciences GILD Stock Holding History

Collective Family Office’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4,226	Closed	-$317K	–	178
2023 Q3	$317K	Sell	4,226 -416	-9%	-$32K	0.12%	126
2023 Q2	$358K	Buy	+4,642	New	+$370K	0.14%	126
2023 Q1	–	Sell	-2,407	Closed	-$207K	–	171
2022 Q4	$207K	Sell	2,407 -1,696	-41%	-$134K	0.09%	163
2022 Q3	$253K	Sell	4,103 -1,200	-23%	-$75.7K	0.13%	149
2022 Q2	$328K	Sell	5,303 -5,675	-52%	-$351K	0.14%	140
2022 Q1	$653K	Buy	10,978 +3,473	+46%	+$222K	0.25%	102
2021 Q4	$545K	Sell	7,505 -367	-5%	-$25.3K	0.21%	109
2021 Q3	$550K	Sell	7,872 -635	-7%	-$44.6K	0.24%	97
2021 Q2	$586K	Sell	8,507 -444	-5%	-$29.6K	0.25%	98
2021 Q1	$579K	Sell	8,951 -750	-8%	-$48.4K	0.28%	91
2020 Q4	$565K	Buy	+9,701	New	+$585K	0.31%	79

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Collective Family Office's GILD Position: Q4 2023 in Review

Collective Family Office sold out of Gilead Sciences (GILD) in Q4 2023, closing a stake of 4,226 shares — an estimated $317K sold.

Collective Family Office first reported a position in GILD in Q4 2020 and held it in 11 quarters. The position peaked at $653K in Q1 2022. 1,775 funds tracked by Wall St. Rank hold GILD as of Q4 2023.

Collective Family Office reported no remaining Gilead Sciences position as of Q4 2023 after selling out during the quarter.
Collective Family Office sold 4,226 Gilead Sciences shares in Q4 2023, an estimated $317K.
Collective Family Office first reported a position in Gilead Sciences in Q4 2020 and held it in 11 quarters.
Collective Family Office's Gilead Sciences position peaked at $653K in Q1 2022.
1,775 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.

Based on Collective Family Office's 13F filing for Q4 2023, filed 9 Jan 2024.